— Know what they know.
Not Investment Advice

MRUS NASDAQ

Merus N.V.
1W: -7.1% 1M: -6.2% 3M: -4.4% 1Y: +113.9% 3Y: +513.5% 5Y: +390.2%
$90.00
Last traded 2025-12-31 — delisted
NASDAQ · Healthcare · Biotechnology · $6.8B mcap · 70M float · 2.45% daily turnover · Short 55% of daily vol

Cash Flow Trends

Operating Cash Flow
-$186M -30.7% ▼
Capital Expenditures
$2M +58.1% ▲
5Y CAGR: -8.5%
Free Cash Flow
-$188M -28.3% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$89M +57.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$86M-$67M-$131M-$155M-$215M
Depreciation & Amort.$1M$1M$1M$3M$2M
Stock-Based Comp.$9M$17M$25M$26M$46M
Change in Working Capital-$14M$16M-$19M-$26M$24M
Other Non-Cash Items$9M-$27M-$24M$9M-$43M
Operating Cash Flow-$80M-$60M-$150M-$142M-$186M
— Investing Activities —
Capital Expenditures-$1M-$870K-$8M-$4M-$2M
Acquisitions (Net)$163K$0$52K$52K$0
Investment Purchases-$67M-$216M-$220M-$235M-$410M
Investment Sales$67M$70M$230M$212M$192M
Other Investing-$163K$0-$52K-$52K-$163K
Investing Cash Flow-$1M-$147M$3M-$27M-$220M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$1M$17M$999K$4M$37M
Financing Cash Flow$40M$282M$59M$230M$494M
Net Change in Cash-$35M$78M-$93M$57M$89M
Cash End of Period$163M$242M$148M$205M$294M
Free Cash Flow-$81M-$60M-$158M-$146M-$188M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms